[HTML][HTML] Recurrent or primary metastatic cervical cancer: current and future treatments

C Gennigens, G Jerusalem, L Lapaille, M De Cuypere… - ESMO open, 2022 - Elsevier
Despite screening programs for early detection and the approval of human papillomavirus
vaccines, around 6% of women with cervical cancer (CC) are discovered with primary …

Optimal treatment in locally advanced cervical cancer

C Gennigens, M De Cuypere, J Hermesse… - Expert Review of …, 2021 - Taylor & Francis
Introduction: Locally advanced cervical cancer (LACC)(International Federation of
Gynecology and Obstetrics (FIGO) 2009/2018–stages IB2-IVA/IB3-IVA, respectively) is …

Multicentric development and evaluation of 18F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical …

F Lucia, V Bourbonne, C Pleyers, PF Dupré… - European Journal of …, 2023 - Springer
Purpose To develop machine learning models to predict para-aortic lymph node (PALN)
involvement in patients with locally advanced cervical cancer (LACC) before …

A specific immune and lymphatic profile characterizes the pre-metastatic state of the sentinel lymph node in patients with early cervical cancer

C Balsat, S Blacher, M Herfs, M Van de Velde… - …, 2017 - Taylor & Francis
The lymph node (LN) pre-metastatic niche is faintly characterized in lymphophilic human
neoplasia, although LN metastasis is considered as the strongest prognostic marker of …

Added value of para-aortic surgical staging compared to 18F-FDG PET/CT on the external beam radiation field for patients with locally advanced cervical cancer: an …

M De Cuypere, P Lovinfosse, F Goffin… - European Journal of …, 2020 - Elsevier
Objective Extended field chemoradiation is recommended for patients with locally advanced
cervical cancer (LACC) and para-aortic lymph node (PALN) metastases. The radiation …

80 Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer

M Daix, M Angeles, F Migliorelli, A Kakkos, CM Gomez… - 2021 - ijgc.bmj.com
Introduction/Background* The aim was to evaluate the concordance between preoperative
ESMO-ESGO-ESTRO risk classification in early-stage endometrial cancer (EC) assessed by …

Secondary complete cytoreduction in recurrent ovarian cancer: benefit of optimal patient selection using scoring system

E Laas, M Luyckx, M De Cuypere, F Selle… - International Journal of …, 2014 - ijgc.bmj.com
Objective Complete tumor cytoreduction seems to be beneficial for patients with recurrent
epithelial ovarian cancer (REOC). The challenge is to identify patients eligible for such …

Prognostic relevance of celiac lymph node involvement in ovarian cancer

A Martínez, C Pomel, T Filleron… - International Journal of …, 2014 - ijgc.bmj.com
Objective The aim of the study was to report on the oncologic outcome of the disease spread
to celiac lymph nodes (CLNs) in advanced-stage ovarian cancer patients. Methods All …

Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy

C Gennigens, M De Cuypere, L Seidel… - Cancer …, 2020 - Wiley Online Library
Abstract Background Hemoglobin (Hb), white blood cell (WBC), and polymorphonuclear
neutrophil (PMN) blood counts may be correlated with outcomes in patients with locally …

Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography/computed tomography (PET/CT) predict …

M De Cuypere, P Lovinfosse, C Gennigens… - International Journal of …, 2020 - ijgc.bmj.com
Objective The aim of this study was to investigate the prognostic value of metabolic
parameters obtained at pretreatment [18F] fluoro-2-deoxy-D-glucose positron emission …